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Optimization of cerebral blood flow (CBF) is the cornerstone of clinical management in 
a number of neurologic diseases, most notably ischemic stroke. Intrathoracic pressure 
influences cardiac output and has the potential to impact CBF. Here, we aim to quantify 
cerebral hemodynamic changes in response to increased respiratory impedance (RI) 
using a non-invasive respiratory device. We measured cerebral perfusion under varying 
levels of RI (6 cm H2O, 9 cm H2O, and 12 cm H2O) in 20 healthy volunteers. Simultaneous 
measurements of microvascular CBF and middle cerebral artery mean flow velocity 
(MFV), respectively, were performed with optical diffuse correlation spectroscopy and 
transcranial Doppler ultrasound. At a high level of RI, MFV increased by 6.4% compared 
to baseline (p = 0.004), but changes in cortical CBF were non-significant. In a multi-
variable linear regression model accounting for end-tidal CO2, RI was associated with 
increases in both MFV (coefficient: 0.49, p < 0.001) and cortical CBF (coefficient: 0.13, 
p < 0.001), although the magnitude of the effect was small. Manipulating intrathoracic 
pressure via non-invasive RI was well tolerated and produced a small but measurable 
increase in cerebral perfusion in healthy individuals. Future studies in acute ischemic 
stroke patients with impaired cerebral autoregulation are warranted in order to assess 
whether RI is feasible as a novel non-invasive therapy for stroke.
Keywords: cerebral blood flow, cerebral blood flow measurement, cerebral hemodynamics, near-infrared 
spectroscopy, transcranial Doppler, diffuse correlation spectroscopy, respiratory impedance
inTrODUcTiOn
Optimization of cerebral blood flow (CBF) is a cornerstone of clinical management for a number 
of neurological diseases that result in impaired oxygen delivery to the brain, most notably ischemic 
stroke. A decrease in intrathoracic pressure has been shown to increase cerebral perfusion in animal 
models of cardiac arrest and hypotension, but human data are limited (1–4). These effects are likely 
driven by an increase in venous return to the heart (5, 6), which in turn promotes cardiac output 
(CO) (6, 7) and blood pressure (1, 7). While intrathoracic pressure can be manipulated during 
mechanical ventilation, a non-invasive approach can have a similar effect in spontaneously breathing 
patients. A respiratory device incorporating a one-way valve that provides resistance only during the 
inspiratory component of the respiratory cycle, referred to as respiratory impedance (RI), leads to 
augmentation of the inspiratory effort in order to generate enough negative intrathoracic pressure to 
FigUre 1 | Protocol setup: (a) transcutaneous cortical cerebral blood 
flow monitoring by diffuse correlation spectroscopy (Dcs) and middle 
cerebral artery trunk velocity monitoring by transcranial Doppler 
(TcD). (B) A subject prepared for the protocol with all cerebrovascular and 
cardiopulmonary equipment in place.
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overcome the impedance. This device has typically been used for 
respiratory muscle training, but the effect on cerebral perfusion 
in humans is not well studied. The limited data that exist have 
focused on patients with orthostatic hypotension, where RI has 
been shown to increase CBF velocity [measured by transcranial 
Doppler (TCD)] (1), and reduce subjective symptoms (1, 8).
Transcranial Doppler provides an important measure of 
cerebral hemodynamics, capturing blood flow velocity through 
proximal intracranial vessels. This non-invasive, continuous 
measure provides a valuable surrogate to global CBF. Diffuse 
correlation spectroscopy (DCS) is a relatively new optical tech-
nique that permits real-time, continuous, non-invasive bedside 
monitoring of tissue-level CBF using near-infrared light (9–12). 
DCS holds great promise for monitoring cerebral hemodynamics 
(13, 14) and has been validated against other measures of CBF 
such as ASL-MRI (15), Xenon CT (16), TCD (17), phase-encoded 
velocity mapping MRI (18), and fluorescent microspheres (19). 
This instrumentation has also been recently employed to quantify 
changes in CBF associated with position change after stroke (20). 
For this study, we use both DCS and TCD to measure changes in 
cerebral hemodynamics that occur during RI in healthy adults.
MaTerials anD MeThODs
study Population
Twenty healthy adult volunteers were enrolled in this study at the 
Hospital of the University of Pennsylvania between August 2015 
and October 2015. Subjects were eligible for the study if they were 
over 18 years of age but were excluded if any of the following were 
present: history of stroke or transient ischemic attack, known cer-
ebrovascular disease, history of congestive heart failure, history 
of COPD, prior neurosurgical procedure, history of brain tumor, 
or active pregnancy. Subjects with well-controlled vascular risk 
factors, such as hypertension and hyperlipidemia, were permit-
ted to participate in the study. The protocol was approved by the 
University of Pennsylvania Institutional Review Board (Protocol 
Number 822204). Written informed consent was signed by each 
participant prior to enrollment.
cBF Monitoring
Diffuse correlation spectroscopy provides a transcranial meas-
urement of relative CBF. Briefly, the temporal fluctuations of 
near-infrared light scattered by moving red blood cells in tissue 
are detected. These fluctuations are quantified by the light inten-
sity temporal autocorrelation function. Its decay rate is related to 
changes in CBF (21). Our instrument employed a long-coherence-
length laser operating at 785 nm and four single-photon counting 
avalanche photodiode detectors for each hemisphere (i.e., a total 
of two lasers and eight detectors). Optical fibers were used to 
couple sources and detectors to the head via 2 cm × 5 cm rubber 
optical probes that were placed bilaterally at the temporal margin 
of the forehead, superior to the frontal sinuses; this configuration 
enabled measurement of tissues supplied by the anterior middle 
cerebral artery (MCA). The distance between the source and 
detector fibers was 2.5 cm, permitting average light penetration 
through the cortical surface (~1.25 cm). An elastic headband was 
placed over the optical probes to maintain secure contact during 
the course of the protocol (Figure 1). Data were collected from 
both hemispheres at a sampling frequency of 1 Hz. Mean CBF 
was calculated for each segment of the protocol after discarding 
10 s preceding and 20 s following each RI transition. This protocol 
helped to negate spurious motion-induced signal fluctuations 
and enabled stabilization after each transition.
Blood Flow Velocity Monitoring
Mean flow velocity (MFV) within the MCA was assessed in all 
subjects using a Compumetics DWL TCD System (Compumetics 
Ltd., Singen, Germany). Probes were secured using a DiaMon® 
adjustable headframe (Figure  1). MCA trunks were insonated 
bilaterally via transtemporal windows at a depth of 40–65 mm. 
Emphasis was placed on obtaining reliable signal from one MCA, 
as there was no expectation of asymmetry in this population of 
healthy volunteers. MFV waveforms were sampled at a rate of 
25  Hz, time-synchronized, and recorded on a computer with 
DCS-measured CBF. Average values were calculated for each 
segment of the protocol, i.e., after discarding 10  s preceding 
and 20  s following each RI transition. This protocol helped to 
negate spurious motion-induced signal fluctuations and enabled 
stabilization after each transition.
cardiopulmonary Monitoring
A finger photophlethysmogaph (Finapres Medical Systems, 
Arnhem, Netherlands) was placed on the right wrist and third 
digit of the right hand and provided continuous measurement of 
mean arterial pressure (MAP), systolic blood pressure, heart rate 
(HR), and CO. A transcutaneous pulse-oximeter was placed on 
the second digit of the right hand for continuous measurement of 
oxygen saturation. The RI device was coupled with a sensor that 
provided continuous measurements of both end-tidal CO2 and 
respiratory rate (Figure 1). All cardiopulmonary waveforms were 
digitized, time-synchronized, and recorded on a computer with 
DCS-measured CBF at a sampling frequency of 25 Hz. Average 
values were calculated for each segment of the protocol after 
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discarding 10 s preceding and 20 s following each RI transition, 
in order to negate spurious motion-induced signal fluctuations 
and enable stabilization after each transition.
ri Protocol
The Philips Inspiratory Muscle Trainer (IMT; Philips Respironics) 
was utilized to non-invasively augment RI. The device has a one-
way, spring-loaded valve, which provides an adjustable resistance 
during inspiration only. No resistance is imposed during expira-
tion. When the device is in place, inspiratory effort must increase 
in order to generate sufficient negative intrathoracic pressure to 
overcome the selected resistance. Three discrete levels of resist-
ance were tested (6 cm H2O, 9 cm H2O, and 12 cm H2O). Every 
subject was exposed to all three levels of resistance in a prespeci-
fied random order.
Each subject was positioned in a hospital bed, with the 
head-of-bed at 45°. Baseline hemodynamic data were collected 
for 5  min, during which the subject was breathing through a 
respiratory mouthpiece providing no resistance. The IMT was 
then mounted to the back of the respiratory mouthpiece for a 
3-min RI segment, during which the subject was instructed to 
breathe naturally through the IMT and maintain a relatively 
stable respiratory rate, in order to avoid fluctuations in end-tidal 
CO2, if possible. If fluctuation in respiratory rate or end-tidal CO2 
occurred, the subject was reminded to breathe comfortably at a 
normal rate, but more intensive attempts to coach breathing were 
avoided. After 3 min of RI, the IMT was removed for 3 min. This 
6-min cycle was repeated for each level of resistance. Subjects 
were blinded to the level of resistance. At the completion of the 
study protocol, subjects were asked if they experienced short-
ness of breath, chest pain, fatigue, and lightheadedness. A single 
Neurologist at the Hospital of the University of Pennsylvania 
was familiar with the protocol and present for the entirety of the 
protocol. The protocol was carried out in the CBF lab, within the 
Hospital of the University of Pennsylvania.
statistical analyses
All data processing was performed while blinded to the level of 
RI. Mean cerebral perfusion (using both CBF and MFV) values 
for each RI segment were compared to the preceding 3 min of 
normal breathing. Pairwise comparisons were completed using 
the Wilcoxon signed-rank tests. Kruskal–Wallis test and Cuzick’s 
non-parametric test of trend were used to compare perfusion 
measures across all RI segments. Additionally, mixed-effects linear 
regression was employed, using a maximum likelihood to model 
changes in DCS and TCD across levels of RI. Models incorporated 
a random slope, and the covariance was modeled as unstructured. 
This approach was used in a prior study of DCS–CBF and head-of-
bed manipulation (20). DCS and TCD were dependent variables. 
Level of RI was the independent variable and was considered to 
be an interval variable. The subject variable was included in the 
model to assess possible individual variability. End-tidal CO2 was 
included in the model in order to account for possible device-
related effects, which may influence perfusion, independent of the 
proposed mechanism. Specifically, subjects were encouraged to 
breathe at a normal rate, yet if the device caused them to hyper-
ventilate, MFV and CBF would be expected to decrease. Blood 
pressure and CO were not included in the model because they are 
expected to be on the causal pathway, rather than confounders. In 
a secondary analysis, the mixed-effects regression was repeated 
without the inclusion of end-tidal CO2, and the level of RI was 
considered to be categorical rather than interval.
The sample size was derived from prior TCD data in human 
subjects (1), from which we estimated a 10% mean increase in 
MFV associated with RI (SD 10%). Setting power to 0.80 and 
significance to 0.05, 16 healthy controls would be sufficient to 
demonstrate the effect of the intervention. No previous literature 
exists to provide expectations of mean increase in DCS-derived 
CBF associated with RI. However, considering the relative simi-
larity between perfusion changes measured with TCD and DCS 
(17, 20), we posit that the sample size calculations used for TCD 
measures will be applicable for CBF measured with DCS.
resUlTs
The study enrolled 20 consecutive healthy volunteers. The average 
age was 39 years (SD: 11 years). Fifty-five percent of volunteers 
were male, and 70% were Caucasian. Vascular risk factors were 
uncommon in the cohort: 10% had hypertension, 15% hyper-
lipidemia, 10% asthma, and no subjects had diabetes or coronary 
artery disease. No subjects were taking beta-blockers. Also, 5% 
were taking nodal acting calcium channel blockers, and 10% were 
taking inhaled bronchodilators. There were no adverse events 
associated with the IMT device. Specifically, no subjects reported 
shortness of breath, chest pain, fatigue, or lightheadedness. No 
subjects elected to terminate the protocol before completion, and 
there were no documented episodes of hypoxia, hypoventilation, 
or hyperventilation.
Figure  2 provides an example of the raw time series data 
acquired from the study of one subject, where there is augmenta-
tion of both cortical CBF and MCA flow velocity during each level 
of RI, most notable with the highest level of RI. Figure 3 depicts 
the relationship between blood flow and RI averaged across the 
cohort. There was a 6.4% increase in TCD-measured MFV at 
the maximum level of resistance (12 cm H2O) (p = 0.004), but 
no significant change from baseline was noted at the low and 
medium levels of RI. Pairwise testing similarly compared DCS-
measured CBF at each level of RI (in comparison to baseline), and 
while no significant differences were identified, point estimates 
suggest a subtle dose–response relationship between CBF and RI. 
Table 1 depicts all hemodynamic data, including MAP, HR, CO, 
and end-tidal CO2 across the range of RI. Similar to the change 
in MFV, an increase in MAP was noted with the highest level of 
RI. Importantly, when averaged over the cohort, there were no 
significant changes in end-tidal CO2.
When all levels of RI were compared by Kruskal–Wallis test, 
both TCD and DCS were significantly different across levels 
(p <  0.001 for both measures). A Cuzick’s non-parametric test 
of trend confirmed that this difference across levels of RI was 
ordered for both TCD and DCS (p < 0.001 for both measures). 
To better quantify the trend, mixed-effects linear regression was 
employed, incorporating end-tidal CO2 and individual variability 
in the model, this approach demonstrated that level of RI was 
associated with both TCD-measured MFV (coefficient: 0.49, 
FigUre 3 | The effect of respiratory impedance on cerebral perfusion: 
box-and-whisker plots represent medians, inter-quartile ranges, and 
the full range of the data. The two additionally plotted points represent 
outliers. *p < 0.005 by Wilcoxon signed-rank tests. CBF, cerebral blood flow; 
DCS, diffuse correlation spectroscopy; TCD, transcranial Doppler; MFV, 
mean flow velocity.
FigUre 2 | cBF and MFV time series: an example of hemodynamic changes throughout the protocol for one subject, (a) middle cerebral artery MFV 
and (B) cortical cBF. CBF, cerebral blood flow; TCD, transcranial Doppler; DCS, diffuse correlation spectroscopy; MFV, mean flow velocity.
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p < 0.001) and DCS-measured microvascular CBF (coefficient: 
0.13, p < 0.001). The larger coefficient for MFV suggests that RI 
had a greater effect on flow through the intracranial trunk vessels 
as compared to cortical tissue perfusion, although the magnitude 
of effect was small overall. Post-estimation predicted probabilities 
suggest that RI of 12 cm H2O, relative to no RI, was associated 
with a 5.8% increase in TCD MFV and a 1.2% increase in CBF. 
Values predicted by the linear model were very similar to meas-
ured values at 6 cm H2O, 9 cm H2O, and 12 cm H2O. Removal 
of end-tidal CO2 did not influence the model for TCD or DCS. 
In the mixed-effects models, a Wald test identified significant 
variability between individuals for both TCD (p <  0.001) and 
DCS (p <  0.001). In a secondary analysis, the level of RI was 
considered to be categorical rather than interval, but the model 
was not significantly affected.
DiscUssiOn
Non-invasive RI proved to be well tolerated and holds promise 
as a bedside intervention to augment cerebral perfusion. In this 
study of healthy volunteers, RI resulted in a small but significant 
increase in MFV measured by TCD. Brain tissue flow measured 
by DCS did not show a significant change as compared to baseline, 
but there appears to be a linear relationship between the level of 
RI and the resultant increase in both MCA trunk and tissue-level 
flow, independent of end-tidal CO2, although the magnitude of 
change was small. Changes in end-tidal CO2 are proportional to 
changes in CBF through its potent effect of vasomotor control 
(22, 23). Because RI influences the respiratory cycle, care was 
taken to quantify respiratory rate and end-tidal CO2 to ensure 
that the measured hemodynamic effects were a result of RI rather 
than a surrogate effect. While the effect of RI on TCD has been 
previously studied, the current study is the first to utilize measures 
of tissue-level cortical CBF and compare the perfusion response 
across three levels of RI.
In the comparison of individual medians, a significant 
increase from baseline flow was only noted by TCD at the high-
est level of resistance. This may indicate a threshold of effect, but 
more likely it is due to limited power to detect small differences. 
Similarly, DCS was unable to identify a significant change in 
tissue flow. The point estimates indicate a dose–response rela-
tionship, although, again, the absolute differences were small, 
and the study was not powered to detect these differences. The 
mixed-effects regression model for both TCD and DCS has 
greater power because it incorporates repeated measures for 
each subject. This model demonstrated a statistically significant 
increase in both DCS and TCD as RI increased, although the 
absolute difference was low.
The discrepancy between TCD and DCS may reflect the fact 
that the two technologies are monitoring different components of 
the vascular system. For example, the increase in MAP at the high-
est level of RI mirrored changes in MCA velocity. Cerebrovascular 
autoregulation, which is largely imposed at the arteriolar level (24, 
25), may dampen the effect at the tissue level, resulting in a non-
significant increase in DCS-measured CBF. Patient populations 
with impaired autoregulation may demonstrate greater effects of 
RI. While there are little human data available for comparison, 
a study of patients with orthostatic hypotension demonstrated 
a 10% increase in MFV with 7  cm H2O resistance (1), while a 
study of normovolemic healthy volunteers found that RI reduced 
TaBle 1 | hemodynamic changes with respiratory impedance (ri): % changes relative to baseline.
6 cm h2O p-Value 9 cm h2O p-Value 12 cm h2O p-Value p for trend
Cerebral blood flow (diffuse correlation 
spectroscopy)
+0.5% (−2.7 to 2.5) 0.82 +1.6% (−2.4 to +6.9) 0.18 +2.7% (−3.4 to +5.4) 0.46 <0.001
Blood flow velocity (transcranial Doppler) +0.2% (−2.5 to +9.4) 0.23 −0.1% (−4.7 to 11.7) 0.79 +6.4% (+1.1 to +11.0) 0.004 <0.001
Mean arterial pressure +1.0% (−1.9 to +2.9) 0.22 +0.3% (−0.6 to +2.5) 0.25 +1.7% (+0.6 to +3.5) 0.006 0.005
Heart rate +1.7% (−2.9 to +4.3) 0.33 +1.8% (−1.9 to +5.8) 0.13 +0.3% (−3.6 to +2.9) 0.88 0.36
End-tidal CO2 −2.8% (−8.5 to +0.1) 0.10 −1.0% (−10.0 to +3.5) 0.30 +1.2% (−1.6 to +7.3) 0.23 0.90
Cardiac output −0.1% (−1.7 to +1.0) 0.77 +1.1% (−0.9 to +2.5) 0.22 +0.8% (−1.1 to +2.4) 0.25 0.17
All reported values are median and IQR. All values are reported as percentages, relative to the baseline period immediately preceding RI. p-Values were calculated by Wilcoxon 
signed-rank tests, in comparison to baseline values (3-min rest period immediately prior to each intervention). Non-parametric test for trend was performed across ordered groups 
and reported in the final column.
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symptoms generated by orthostatic maneuvers but yielded no 
objective effect on MFV (8).
Mechanistically, RI decreases intrathoracic pressure, which in 
turn increases venous return to the heart and ventricular preload 
(5, 6). Depending on volume status and cardiac function, the 
Frank–Starling law indicates that an increase in preload results 
in an increase in cardiac stroke volume, as previously observed 
(6, 7), which in turn increases vital organ perfusion, including 
brain perfusion (2, 26). This physiologic mechanism is more 
impactful in the context of hypovolemia (27, 28), and the modest 
effect measured in the current study may be a consequence of 
the subjects’ volume status. Additionally, as noted above, cerebral 
autoregulation may dampen the augmentation of tissue perfusion 
with RI. So, although we observed a small magnitude of effect 
in healthy volunteers, other populations may experience greater 
increases in CBF. For example, ischemic stroke impairs cerebro-
vascular autoregulation, and many patients with acute stroke 
present to the hospital in a hypovolemic state, which is associated 
with worse outcome (29, 30). As such, RI may achieve more 
significant increases in cerebral perfusion in patients with acute 
ischemic stroke, which will be an important area of future study.
Based on the proposed mechanism of increased cardiac 
preload, it may be surprising that RI did not increase CO, as was 
previously reported (31). It is worth noting that the Finapres con-
tinuous hemodynamic monitor does not directly measure cardiac 
stroke volume. Rather, it calculates stroke volume and CO based 
on the contour of the blood pressure waveform, so technical 
limitations should temper the confidence in this measurement. 
Still, prior studies of RI that have measured an increase in CO 
have used a similar approach (31, 32). The discrepancy between 
these findings may relate to the underlying volume status of the 
study subjects, but it would also be reasonable to consider more 
direct measure of stroke volume and CO in future studies.
An additional mechanism by which RI may increase cerebral 
perfusion is through manipulation of intracranial pressure (ICP). 
In animal models, decreases in ITP have been shown to result in 
reduced ICP (33, 34). This may occur because of the increased 
venous return through the jugular veins or spinal venous system. 
The potential relationship between ITP and ICP has not been 
studied in spontaneously breathing humans, and because the 
effect of interest in the current study was cerebral perfusion, 
an emphasis was placed on perfusion monitoring rather than 
a mechanistic evaluation, but potential mechanism could be 
explored in future studies.
Adjusting for end-tidal CO2 in the regression analysis did not 
diminish the effect of RI. Still, end-tidal CO2 should be a key 
component of future studies, because if a subject were to hyper-
ventilate during RI, the resultant hypocapnia could be expected 
to influence vasomotor tone and flow, confounding results (22, 
23). Over a longer period of time, which would be required for 
any kind of clinical utility, there is a theoretical possibility of res-
piratory fatigue, though this was not observed under the current 
protocol. RI was well tolerated, without any reported shortness 
of breath, lightheadedness, fatigue, or chest pain. Continuous 
pulse-oximetry demonstrated maintenance of appropriate blood 
oxygen saturation throughout the protocol. Low levels of RI have 
been shown to nearly double the work of normal physiologic 
breathing, without signs of intolerance, but again less than 
10 min of RI was tested (35). Prior studies have exposed subjects 
to periods of RI greater than 10 min, with good tolerability (8, 31), 
showcasing the potential of using this intervention over longer 
time scales than tested in this study.
There are several limitations of the current study. Most notably, 
the detected changes in perfusion were smaller than anticipated, 
so the sample size was not powered to identify significant changes 
in perfusion during lower levels of RI. RI was limited to 3 min, 
so conclusions cannot directly be drawn about the effects of 
prolonged use. The volume status of each volunteer also serves 
as a significant confounder, and because volume status was not 
objectively quantified in this cohort, adjustment was not possible. 
Response to RI may be confounded by volume status, cardiac 
function, or dysrhythmia, which was not objectively assessed 
in this cohort. In addition, DCS signals cannot be reliably 
recorded through hair. Thus, tissue perfusion data are restricted 
to the frontal lobe, leaving other territories and deeper structures 
unmeasured. While TCD is a commonly used surrogate of CBF, it 
more specifically measures blood flow velocity through the MCA 
trunk, so one must assume a constant arterial diameter in order 
to use TCD as a reliable surrogate. This is a general limitation 
of TCD, but in the current study, we avoided such assumptions 
by also using DCS, a direct CBF monitor. A fairly homogenous 
population limited generalizability to specific patient populations, 
but the intent of this study was to demonstrate tolerability and 
potential for effect. Because the acute stroke population stands to 
benefit from an intervention that augments CBF, that population 
will be the subject of future study. In the study of stroke patients, 
attention should be paid to volume status, duration of RI, cardiac 
function, dysrhythmia, and infarct location.
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cOnclUsiOn
Manipulating intrathoracic pressure via non-invasive RI was 
well tolerated and resulted in a small but measurable increase 
in cerebral perfusion in healthy individuals. While flow changes 
were not identified at low levels of resistance, there was a linear 
relationship between the level of resistance and both MCA flow 
and tissue flow measures. Future study in ischemic stroke patients 
will assess whether RI has any utility as a novel non-invasive 
therapy for acute ischemic stroke treatment.
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